Skip to main content
Figure 1 | Respiratory Research

Figure 1

From: The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD

Figure 1

Pgp1 + T, NKT-like and NK cells in COPD and control subjects. Data presented as box plots. There was a significant increase in the percentage of Pgp1 + NKT-like and Pgp1 + NKcells in COPD patients (grey bars) compared with control subjects (clear bars). The percentage of Pgp1 + NKT-like and Pgp1 + NK cells was greater than the percentage of Pgp1 + T cells for COPD patients but not control subjects (p > 0.05 for all).

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us